Get the Stockscreener App
125.97
3.45%
-4.34
After Hours:
125.89
-0.08
-0.06%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Teleflex Incorporated stock is traded at $125.97, with a volume of 977.71K.
It is down -3.45% in the last 24 hours and up +4.26% over the past month.
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
See More
Previous Close:
$130.31
Open:
$130.38
24h Volume:
977.71K
Relative Volume:
1.71
Market Cap:
$5.57B
Revenue:
$3.03B
Net Income/Loss:
$237.44M
P/E Ratio:
25.04
EPS:
5.03
Net Cash Flow:
$450.04M
1W Performance:
-3.35%
1M Performance:
+4.26%
6M Performance:
-8.64%
1Y Performance:
-48.87%
1-Day Range:
$123.53
$131.44
1-Week Range:
$123.53
$133.18
52-Week Range:
$108.90
$249.91
Teleflex Incorporated Stock (TFX) Company Profile
Name
Teleflex Incorporated
Sector
Industry
Phone
610-225-6800
Address
550 E SWEDESFORD RD, WAYNE, PA
Compare TFX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TFX
Teleflex Incorporated
|
125.97 | 5.76B | 3.03B | 237.44M | 450.04M | 5.03 |
|
ISRG
Intuitive Surgical Inc
|
433.87 | 161.20B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
185.75 | 53.55B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
271.39 | 39.55B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
77.40 | 38.71B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
257.54 | 18.23B | 2.96B | 487.70M | 344.00M | 6.68 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-28-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-28-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-28-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Feb-27-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Jul-01-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-21-23 | Downgrade | Needham | Buy → Hold |
| May-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-26-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-26-22 | Initiated | Mizuho | Neutral |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-29-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-09-22 | Initiated | BofA Securities | Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-07-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-07-21 | Resumed | Raymond James | Outperform |
| Jul-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jan-06-21 | Reiterated | Needham | Buy |
| Nov-02-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-31-20 | Reiterated | Needham | Buy |
| Aug-02-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Wells Fargo | Outperform |
| Apr-24-19 | Downgrade | Needham | Strong Buy → Buy |
| Feb-22-19 | Reiterated | Needham | Strong Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Sep-10-18 | Upgrade | Needham | Buy → Strong Buy |
| Aug-03-18 | Reiterated | Needham | Buy |
| May-14-18 | Reiterated | Needham | Buy |
| May-04-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Initiated | Goldman | Neutral |
| Nov-10-17 | Resumed | Piper Jaffray | Overweight |
| Nov-03-17 | Reiterated | Needham | Buy |
| Sep-08-17 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Sep-06-17 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-06-17 | Reiterated | Needham | Buy |
| Mar-07-17 | Initiated | Needham | Buy |
| Jan-06-17 | Upgrade | Jefferies | Hold → Buy |
| Jul-12-16 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Teleflex Incorporated Stock (TFX) Latest News
Should Value Investors Buy Teleflex (TFX) Stock? - Yahoo Finance
MetLife Investment Management LLC Cuts Stake in Teleflex Incorporated $TFX - MarketBeat
Teleflex In 2025: A Company Trying To Reset (NYSE:TFX) - Seeking Alpha
United Services Automobile Association Invests $373,000 in Teleflex Incorporated $TFX - MarketBeat
Teleflex Incorporated $TFX Shares Sold by Corebridge Financial Inc. - MarketBeat
Millennium Management LLC Grows Holdings in Teleflex Incorporated $TFX - MarketBeat
Teleflex (NYSE:TFX) Upgraded at Wall Street Zen - MarketBeat
Sepio Capital LP Raises Stake in Teleflex Incorporated $TFX - MarketBeat
AQR Capital Management LLC Purchases 20,225 Shares of Teleflex Incorporated $TFX - MarketBeat
The past five years for Teleflex (NYSE:TFX) investors has not been profitable - Yahoo Finance
Teleflex enrols first patient in DUBSTENT DIABETES trial - Yahoo Finance
First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients - GlobeNewswire
Teleflex enrolls first patient in dual-drug-eluting device study of coronary interventions for diabetes - MassDevice
Teleflex Incorporated Announces the Enrollment of the First Patient in the DUBSTENT DIABETES trial - MarketScreener
These 4 Measures Indicate That Teleflex (NYSE:TFX) Is Using Debt Reasonably Well - simplywall.st
Teleflex Incorporated Initiates DUBSTENT DIABETES Trial to Evaluate Dual-Device Strategy for PCI in Diabetic Patients - Quiver Quantitative
First-of-its-kind Trial: Teleflex Tests Revolutionary Dual-Device Strategy for Diabetic Heart Patients - Stock Titan
Teleflex Incorporated $TFX is Invenomic Capital Management LP's 4th Largest Position - MarketBeat
Teleflex at Morgan Stanley Conference: Strategic Reorganization and Growth Plans - Investing.com
Hsbc Holdings PLC Has $303,000 Position in Teleflex Incorporated $TFX - MarketBeat
Transcript : Teleflex Incorporated Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-09-2025 03 - MarketScreener
Vident Advisory LLC Acquires Shares of 8,850 Teleflex Incorporated $TFX - MarketBeat
Canada Pension Plan Investment Board Has $5.74 Million Stock Holdings in Teleflex Incorporated $TFX - MarketBeat
Moving Average Crossover Confirms Uptrend in Teleflex Incorporated2025 Price Momentum & Weekly Consistent Profit Watchlists - beatles.ru
MACD Signals Flash Warning for Teleflex Incorporated Stock2025 AllTime Highs & Free Safe Capital Growth Stock Tips - beatles.ru
Will Teleflex Incorporated outperform during market ralliesTrade Signal Summary & Verified Short-Term Trading Plans - beatles.ru
American Century Companies Inc. Has $1.42 Million Stock Position in Teleflex Incorporated $TFX - MarketBeat
What indicators show strength in Teleflex IncorporatedQuarterly Earnings Summary & High Yield Stock Recommendations - Newser
Teleflex Incorporated $TFX Shares Purchased by Comerica Bank - MarketBeat
Is Teleflex Incorporated attractive for institutional investorsTrade Exit Summary & Safe Capital Preservation Plans - خودرو بانک
Is now the right time to enter Teleflex IncorporatedDollar Strength & High Accuracy Trade Alerts - خودرو بانک
How sentiment analysis helps forecast Teleflex Incorporated2025 Volume Leaders & Safe Capital Growth Trade Ideas - Newser
Can Teleflex Incorporated continue delivering strong returns2025 Biggest Moves & Weekly Return Optimization Plans - خودرو بانک
Real time scanner hits for Teleflex Incorporated explainedStock Surge & Expert Curated Trade Setups - Newser
How to use a screener to detect Teleflex Incorporated breakouts2025 Historical Comparison & Smart Investment Allocation Tips - Newser
Teleflex Incorporated (NYSE:TFX) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Will breakout in Teleflex Incorporated lead to full recoveryJuly 2025 Price Swings & Fast Entry Momentum Trade Alerts - Newser
Teleflex Incorporated stock trendline breakdown2025 Momentum Check & High Accuracy Swing Trade Signals - Newser
teleflex incorporated stock trendline breakdownWeekly Trade Recap & Free Low Drawdown Momentum Trade Ideas - Newser
Will Teleflex Incorporated benefit from macro trendsQuarterly Earnings Report & Real-Time Volume Trigger Notifications - Newser
Teleflex Incorporated's (NYSE:TFX) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? - 富途牛牛
Surprises Report: Will Teleflex Incorporated outperform during market ralliesPortfolio Risk Summary & Reliable Breakout Stock Forecasts - خودرو بانک
Using R and stats models for Teleflex Incorporated forecastingWeekly Market Outlook & Weekly Chart Analysis and Trade Guides - Newser
Teleflex Incorporated stock retracement – recovery analysisJuly 2025 Sentiment & Stock Portfolio Risk Management - Newser
What Fibonacci levels say about Teleflex Incorporated reboundJuly 2025 Sector Moves & Risk Managed Trade Strategies - Newser
Wall Street Zen Downgrades Teleflex (NYSE:TFX) to Buy - MarketBeat
What institutional flow reveals about Teleflex Incorporated2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - Newser
Teleflex Secures Contract with Vizient to Supply Vascular Access Products - MSN
Reversal indicators forming on Teleflex Incorporated stockJuly 2025 Intraday Action & AI Enhanced Execution Alerts - Newser
How volatile is Teleflex Incorporated stockJuly 2025 Selloffs & Smart Allocation Stock Tips - خودرو بانک
What’s the recovery path for long term holders of Teleflex IncorporatedJuly 2025 Retail & Risk Adjusted Buy/Sell Alerts - Newser
Teleflex Incorporated Stock (TFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.46%
1.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):